Work Here?
About Science
Industries
Consulting
Industrial & Manufacturing
Biotechnology
Company Size
201-500
Company Stage
Late Stage VC
Total Funding
$126M
Headquarters
Alameda, California
Founded
2021
Overview
Science.xyz develops specialized products and services in the biotech and high-tech sectors, focusing on areas like synthetic biology, stem cell research, microfabrication, and semiconductor devices. The company employs a skilled team of professionals, including scientists and engineers, to ensure their offerings are advanced and effective. Unlike many competitors, Science.xyz emphasizes collaboration with academic institutions and research labs, which helps them stay connected to the latest scientific developments. Their goal is to provide valuable technological solutions that support research and innovation in various scientific fields.
Simplify's Take
What believers are saying
- Science Corp. raised over $100 million to advance brain-computer interface technologies.
- The acquisition of Pixium Vision SA's technology enhances Science Corp.'s capabilities in biotech.
- Strategic location in Alameda, California, offers growth opportunities in the biotech sector.
What critics are saying
- Increased competition in the BCI market may impact Science Corp.'s market share.
- Regulatory hurdles for CE Mark approval could delay the PRIMA retinal implant launch.
- Dependence on biohybrid neural interfaces' success poses potential technical challenges.
What makes Science unique
- Science Corp. focuses on biohybrid neural interfaces, combining biological and electronic components.
- The company is pioneering neuron-based brain-computer interfaces to minimize brain damage.
- Science Corp. has developed the Synapse protocol, a flexible API for neural interface devices.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$126M
Above
Industry Average
Funded Over
2 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Flexible Vacation
Paid Parental Leave
Paid Sick Leave
401(k) Retirement Plan
Dependent Care Flexible Spending Account
Flexible Spending Account
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↑ 5%2 year growth
↑ 8%Science Corp. is developing the next version of the implant and glasses which will optimize visual performance further with digital image processing, streamlined ergonomics, and increased visual resolution to bring this technology to more patients.
New funding follows impressive vision restoration results in advanced AMD patients using retinal implant system.
Science Corp, a neurotech firm founded by Neuralink co-founder Max Hodak, has raised over $100 million in funding led by Khosla Ventures. This adds to the $186 million previously raised. The funding will accelerate the development and commercialization of their brain-computer interface technologies, including the PRIMA retinal implant system for vision restoration in advanced AMD patients. The system uses a wireless implant and specialized glasses to help patients perceive visual forms.
Science Corp., a technology company focused on the human brain started by Neuralink Corp. co-founder Max Hodak, has raised over $100 million in a funding round led by Khosla Ventures.
Science Corporation, a U.S. BCI company, is developing a method that secures more communication channels using neurons instead of inserting metal electrodes into the brain, while minimizing brain damage.
Science is Hiring for 10 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Science
Industries
Consulting
Industrial & Manufacturing
Biotechnology
Company Size
201-500
Company Stage
Late Stage VC
Total Funding
$126M
Headquarters
Alameda, California
Founded
2021
Science is Hiring for 10 Jobs on Simplify!
Find jobs on Simplify and start your career today